Analyst Ratings For Quest Diagnostics Incorporated (NYSE:DGX)

Today, Quest Diagnostics Incorporated (NYSE:DGX) stock was downgraded by Goldman Sachs Group, Inc. (The) from Conviction-Buy to Buy.

There are 1 sell rating, 7 hold ratings, 6 buy ratings on the stock.

The current consensus rating on Quest Diagnostics Incorporated (NYSE:DGX) is Hold (Score: 2.36) with a consensus target price of $108.75 per share, a potential 19.43% upside.

Some recent analyst ratings include

• 10/10/2017-Goldman Sachs Group, Inc. (The) was Downgraded by analysts at Goldman Sachs Group, Inc. (The) from a “Conviction-Buy ” rating to a ” Buy” rating.
• 9/25/2017-Raymond James Financial, Inc. Reiterated Rating of Outperform .
• 9/13/2017-Canaccord Genuity Reiterated Rating of Buy.
• 7/25/2017-Bank of America Corporation Upgrade from a “Neutral ” rating to a ” Buy” rating.

Dividend information for Quest Diagnostics Incorporated (NYSE:DGX)

Quest Diagnostics Incorporated (NYSE:DGX) pays an annual dividend of Community Ranking: with a yield of 1.98% and an average dividend growth of 9.60% based on a 3 Year Average.

Dividend History for Quest Diagnostics Incorporated (NYSE:DGX)

• On 8/18/2017 Quest Diagnostics Incorporated announced a quarterly dividend of $0.45 1.72% with an ex dividend date of 10/2/2017 which will be payable on 10/18/2017.
• On 5/16/2017 Quest Diagnostics Incorporated announced a quarterly dividend of $0.45 1.71% with an ex dividend date of 7/6/2017 which will be payable on 7/24/2017.
• On 2/21/2017 Quest Diagnostics Incorporated announced a quarterly dividend of $0.45 1.88% with an ex dividend date of 4/3/2017 which will be payable on 4/19/2017.
• On 11/11/2016 Quest Diagnostics Incorporated announced a quarterly dividend of $0.45 with an ex dividend date of 1/6/2017 which will be payable on 1/25/2017.
• On 8/17/2016 Quest Diagnostics Incorporated announced a quarterly dividend of $0.40 1.88% with an ex dividend date of 9/30/2016 which will be payable on 10/19/2016.
• On 5/18/2016 Quest Diagnostics Incorporated announced a quarterly dividend of $0.40 2.1% with an ex dividend date of 7/1/2016 which will be payable on 7/20/2016.
• On 1/28/2016 Quest Diagnostics Incorporated announced a quarterly dividend of $0.40 2.31% with an ex dividend date of 4/4/2016 which will be payable on 4/20/2016.

Recent Insider Trading Activity For Quest Diagnostics Incorporated (NYSE:DGX)
Quest Diagnostics Incorporated (NYSE:DGX) has insider ownership of 1.75% and institutional ownership of 87.10%.

• On 9/12/2017 Stephen H Rusckowski, Chairman, sold 59,235 with an average share price of $108.16 per share and the total transaction amounting to $6,406,857.60. View SEC Filing
• On 9/11/2017 Daniel Stanzione, Director, sold 40,900 with an average share price of $108.07 per share and the total transaction amounting to $4,420,063.00. View SEC Filing
• On 9/11/2017 Stephen H Rusckowski, CEO, sold 53,933 with an average share price of $108.16 per share and the total transaction amounting to $5,833,393.28. View SEC Filing
• On 9/5/2017 Daniel Stanzione, Director, sold 3,803 with an average share price of $108.01 per share and the total transaction amounting to $410,762.03. View SEC Filing
• On 9/5/2017 Stephen H Rusckowski, Chairman, sold 2,525 with an average share price of $108.03 per share and the total transaction amounting to $272,775.75. View SEC Filing
• On 8/4/2017 Jeffrey M Leiden, Director, sold 296 with an average share price of $106.66 per share and the total transaction amounting to $31,571.36. View SEC Filing
• On 7/27/2017 Jeffrey M Leiden, Director, sold 1,304 with an average share price of $108.73 per share and the total transaction amounting to $141,783.92. View SEC Filing

Recent Trading Activity for Quest Diagnostics Incorporated (NYSE:DGX)
Shares of Quest Diagnostics Incorporated closed the previous trading session at with shares trading hands.